Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.46 - $19.28 $16.9 Million - $43.7 Million
-2,265,701 Closed
0 $4,000
Q2 2022

Aug 15, 2022

SELL
$15.06 - $30.65 $5.93 Million - $12.1 Million
-393,707 Reduced 14.8%
2,265,701 $36.7 Million
Q1 2022

May 16, 2022

SELL
$23.26 - $42.41 $11.4 Million - $20.7 Million
-488,375 Reduced 15.51%
2,659,408 $77.6 Million
Q4 2021

Feb 11, 2022

BUY
$37.54 - $57.51 $546,131 - $836,655
14,548 Added 0.46%
3,147,783 $133 Million
Q3 2021

Nov 12, 2021

BUY
$45.91 - $59.67 $14.2 Million - $18.4 Million
308,393 Added 10.92%
3,133,235 $156 Million
Q2 2021

Aug 13, 2021

BUY
$43.3 - $67.17 $55.5 Million - $86.2 Million
1,282,684 Added 83.17%
2,824,842 $166 Million
Q1 2021

May 14, 2021

BUY
$44.11 - $90.64 $2.51 Million - $5.16 Million
56,981 Added 3.84%
1,542,158 $90.2 Million
Q4 2020

Feb 16, 2021

BUY
$33.89 - $49.88 $1.72 Million - $2.53 Million
50,787 Added 3.54%
1,485,177 $69.1 Million
Q3 2020

Nov 13, 2020

BUY
$26.91 - $37.47 $807,165 - $1.12 Million
29,995 Added 2.14%
1,434,390 $48.4 Million
Q2 2020

Aug 11, 2020

BUY
$19.21 - $28.53 $438,487 - $651,225
22,826 Added 1.65%
1,404,395 $38.5 Million
Q1 2020

May 15, 2020

BUY
$11.17 - $28.72 $488,263 - $1.26 Million
43,712 Added 3.27%
1,381,569 $25.4 Million
Q4 2019

Feb 14, 2020

BUY
$19.29 - $25.52 $4.09 Million - $5.41 Million
211,947 Added 18.82%
1,337,857 $31.6 Million
Q3 2019

Nov 14, 2019

BUY
$21.72 - $35.38 $24.2 Million - $39.4 Million
1,113,263 Added 8802.59%
1,125,910 $24.7 Million
Q2 2019

Aug 14, 2019

SELL
$20.59 - $35.2 $193,484 - $330,774
-9,397 Reduced 42.63%
12,647 $427,000
Q1 2019

May 15, 2019

BUY
$17.28 - $25.83 $286,519 - $428,287
16,581 Added 303.51%
22,044 $569,000
Q4 2018

Feb 15, 2019

BUY
$16.17 - $20.8 $88,336 - $113,630
5,463 New
5,463 $100,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $426M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.